David Rickey
After 13 years of serving on the Board, David Rickey has been named new Chairman at cell therapy developer Cytori Therapeutics, replacing Lloyd Dean who will continue to serve as an independent member of the Company’s Board of Directors.
“Mr. Rickey has played a critical role in Cytori’s growth by providing us with invaluable operational and governance experience during his 13 years as a director,” said Chris Calhoun, CEO of Cytori. “We are grateful to Mr. Dean for his leadership and service as Chairman for the past two years, and look forward his continued service to Cytori and our shareholders into the future.”